Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Receptos
Receptos
Receptos Said to Get M&A Interest Amid Partnership Talks
Bloomberg
Wed, 04/1/15 - 05:29 pm
Receptos
M&A
ozanimod
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Thu, 01/15/15 - 12:05 pm
Receptos
AbbVie
Biogen Idec
JNJ
Novartis
RPC1063
ulcerative colitis
multiple sclerosis
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
biotech
Avanir
OvaScience
Agios
Bluebird Bio
Receptos
Prosensa
Pernix
Achillion
Amicus Therapeutics
CytoSorbents
PTC Therapeutics
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
24/7 Wall St
Tue, 12/30/14 - 10:21 am
Agios Pharmaceuticals
OvaScience
Radius
Prosensa
TG Therapeutics
Bluebird Bio
Receptos
The 5 Best Biotech Stocks in 2014...so far
Motley Fool
Fri, 09/26/14 - 11:42 am
biotech
Intercept Pharmaceuticals
Achillion
Puma Biotechnology
PTC Therapeutics
Receptos
4 Biotechs That Might Be Bought Soon
Investors.com
Fri, 08/29/14 - 02:47 pm
M&A
Achillion
Intercept Pharma
Puma Biotechnology
Receptos
IPO Stock Watch: Receptos Soars On MS Drug Results
Investors.com
Tue, 06/10/14 - 07:22 pm
IPOs
MS
multiple sclerosis
Receptos
RPC1063
Novartis
Gilenya
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs
Seeking Alpha
Fri, 05/16/14 - 08:20 am
Amgen
Biocryst
GSK
Corcept Therapeutics
Merck KGaA
Ligand Pharmaceuticals
MannKind
Pfizer
Shire
Receptos
Opexa
A Year-End Look at 3 High-Flying Biotech IPOs of 2013: PETX, RCPT, STML
Motley Fool
Thu, 12/26/13 - 01:48 pm
IPOs
Receptos
Aratana
Stemline Therapeutics
Biotech Stock Bubble Debate in 14 Charts
TheStreet.com
Wed, 10/23/13 - 08:32 am
biotech
Bluebird Bio
Celgene
Celldex
Onconova
Aegerion
Receptos
Immunomedics
Alcobra
Gilead
Biogen Idec
Ambit Biosciences
Receptos Could Meet With A More Positive Reception
Seeking Alpha
Wed, 08/14/13 - 10:16 am
Receptos
Novartis
Gilenya
MS
multiple sclerosis
RPC1063
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
AbbVie-Receptos Collaborate
Yahoo/Zacks
Tue, 03/19/13 - 10:39 am
Receptos
AbbVie
RPC4046
asthma
Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
Yahoo
Wed, 03/13/13 - 12:19 pm
Receptos
anti-interleukin-13
AbbVie
Pages
« first
‹ previous
1
2